Clinical Trial Update: 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs) [NA]

View source ↗

Summary

A completed clinical trial evaluating Gallium-68 DOTATATE PET-CT for diagnosing neuroendocrine tumors (NETs).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma
• Neuroendocrine Tumor

Drugs mentioned

• 68Ga-DOTATATE (Gallium-68 DOTATATE)

Snippet

Sponsor: Radio Isotope Therapy of America | Conditions: Neuroendocrine Carcinoma | NA | Status: COMPLETED